Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 4/23/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Peggy Harbison?

Peggy Harbison

Senior Vice President

Aria Neurosciences Inc

HQ Phone:  (203) 230-8596

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Aria Neurosciences Inc

295 Washington Ave, Suite S

Hamden, Connecticut,06410

United States

Company Description

Aria Neurosciences, Inc. (Aria) is an emerging biopharmaceutical company dedicated to developing and commercializing novel disease modifying therapies for Alzheimer's disease (AD). Current standard of care therapies are aimed at ameliorating cognitive and be... more

Find other employees at this company (3)

Background Information

Employment History

Lifecycle Leader

Pharma Business


Vice President

Roche Diagnostics Corporation


Web References(7 Total References)


Management

www.arianeurosciences.com [cached]

Peggy Harbison, V.M.D.
Peggy Harbison, V.M.D., Senior Vice President Preclinical and Program Management Dr. Harbison has had 20 years experience in drug and companion diagnostics development at Roche with particular expertise in project leadership, clinical and regulatory strategies, and preclinical drug development. Most recently, she was Vice President at Roche Molecular Diagnostics where she was responsible for a development portfolio of molecular biomarker and companion diagnostics in the Genomics and Oncology business area. Prior to that, Dr. Harbison held global project leadership positions in the Pharma division; she led cross-functional lifecycle teams for drugs in development, both small molecules and biologics, in a variety of therapeutic areas. Her tenure included a 4-year ex-pat assignment in the Basel, Switzerland headquarters and the position of Global Head of Project Management. Dr. Harbison spent her initial years at Roche in preclinical drug development in the Department of Toxicology and Pathology. She is a board-certified veterinary pathologist and holds a B.A. and a Doctorate of Veterinary Medicine (V.M.D) from the University of Pennsylvania. Her pathology training was carried out at Harvard Medical School under an National Institutes of Health post-doctoral fellowship.


Management and Advisors - Welcome to Aria Neurosciences, Inc.

www.arianeurosciences.com [cached]

Peggy Harbison, V.M.D., Senior Vice President Preclinical and Program Management
Dr. Harbison has had 20 years experience in drug and companion diagnostics development at Roche with particular expertise in project leadership, clinical and regulatory strategies, and preclinical drug development. Most recently, she was Vice President at Roche Molecular Diagnostics where she was responsible for a development portfolio of molecular biomarker and companion diagnostics in the Genomics and Oncology business area. Prior to that, Dr. Harbison held global project leadership positions in the Pharma division; she led cross-functional lifecycle teams for drugs in development, both small molecules and biologics, in a variety of therapeutic areas. Her tenure included a 4-year ex-pat assignment in the Basel, Switzerland headquarters and the position of Global Head of Project Management. Dr. Harbison spent her initial years at Roche in preclinical drug development in the Department of Toxicology and Pathology. She is a board-certified veterinary pathologist and holds a B.A. and a Doctorate of Veterinary Medicine (V.M.D) from the University of Pennsylvania. Her pathology training was carried out at Harvard Medical School under an National Institutes of Health post-doctoral fellowship.


Team

www.parspharma.com [cached]

Peggy Harbison, V.M.D., Senior Vice President Preclinical Toxicology/Pharmacology and Project Management
Dr. Harbison has had 20 years experience in drug and companion diagnostics development at Roche with particular expertise in project leadership, clinical strategy, regulatory strategies, and preclinical drug development....


Bios

www.parspharma.com [cached]

Peggy Harbison, V.M.D.
Peggy Harbison, V.M.D. Peggy Harbison, V.M.D., Senior Vice President Preclinical Toxicology/Pharmacology and Project Management Dr. Harbison has had 20 years experience in drug and companion diagnostics development at Roche with particular expertise in project leadership, clinical strategy, regulatory strategies, and preclinical drug development. Most recently, as Vice President at Roche Molecular Diagnostics she was responsible for development of the Genomics and Oncology portfolio of molecular biomarker and companion diagnostics. Prior to that, Dr. Harbison held global project leadership positions in the Pharma division leading cross-functional lifecycle teams for drugs in development. These included small molecules and biologics in a variety of therapeutic areas. Dr. Harbison also served as Global Head of project management. Earlier at Roche. Dr. Harbison built her career in pathology and toxicology. She is a board-certified veterinary pathologist and holds a B.A. and a Doctorate of Veterinary Medicine (V.M.D) from the University of Pennsylvania. Her pathology training was carried out at Harvard Medical School under a National Institutions of Health post-doctoral fellowship.


www.parspharma.com

Peggy Harbison, V.M.D.
Peggy Harbison, V.M.D., Senior Vice President Preclinical Toxicology/Pharmacology and Project Management Dr. Harbison has had 20 years experience in drug and companion diagnostics development at Roche with particular expertise in project leadership, clinical and regulatory strategies, and preclinical drug development. Most recently, she was Vice President at Roche Molecular Diagnostics where she was responsible for a development portfolio of molecular biomarker and companion diagnostics in the Genomics and Oncology business area. Prior to that, Dr. Harbison held global project leadership positions in the Pharma division; she led cross-functional lifecycle teams for drugs in development, both small molecules and biologics, in a variety of therapeutic areas. Her tenure included a 4-year ex-pat assignment in the Basel, Switzerland headquarters and the position of Global Head of project management. Dr. Harbison spent her initial years at Roche in pre-clinical drug development in the Department of Toxicology and Pathology. She is a board-certified veterinary pathologist and holds a B.A. and a Doctorate of Veterinary Medicine (V.M.D) from the University of Pennsylvania. Her pathology training was carried out at Harvard Medical School under an National Institutions of Health post-doctoral fellowship.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory